PLx Pharma Winddown Corp.

2019 Q4 Form 10-Q Financial Statement

#000143774919022041 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.00M $18.51M $16.54M
YoY Change -1.75% 11.91% -45.66%
Cash & Equivalents $14.00M $18.51M $16.54M
Short-Term Investments
Other Short-Term Assets $260.0K $250.0K $560.0K
YoY Change -56.67% -55.36% -5.08%
Inventory $0.00 $0.00
Prepaid Expenses $470.5K
Receivables $20.00K $0.00 $40.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.28M $18.76M $17.14M
YoY Change -3.92% 9.45% -45.51%
LONG-TERM ASSETS
Property, Plant & Equipment $1.467M $1.392M $1.450M
YoY Change 5.19% -3.98% 60.68%
Goodwill $2.061M $2.061M $2.061M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.00K $70.00K $70.00K
YoY Change 0.0% 0.0% 16.67%
Total Long-Term Assets $4.219M $4.227M $3.579M
YoY Change 19.77% 18.11% -32.69%
TOTAL ASSETS
Total Short-Term Assets $14.28M $18.76M $17.14M
Total Long-Term Assets $4.219M $4.227M $3.579M
Total Assets $18.50M $22.99M $20.72M
YoY Change 0.62% 10.95% -43.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $930.0K $1.290M $750.0K
YoY Change 43.08% 72.0% -28.57%
Accrued Expenses $1.510M $1.260M $840.0K
YoY Change 29.06% 50.0% -65.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.658M $3.626M $1.952M
YoY Change 25.72% 85.74%
Total Short-Term Liabilities $6.093M $6.174M $3.541M
YoY Change 28.75% 74.36% 0.99%
LONG-TERM LIABILITIES
Long-Term Debt $622.3K $1.549M $5.175M
YoY Change -85.46% -70.07% -24.65%
Other Long-Term Liabilities $409.4K $488.6K $124.4K
YoY Change 385.79% 292.86% -99.12%
Total Long-Term Liabilities $1.032M $2.037M $5.299M
YoY Change -76.36% -61.55% -22.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.093M $6.174M $3.541M
Total Long-Term Liabilities $1.032M $2.037M $5.299M
Total Liabilities $16.93M $19.53M $17.32M
YoY Change 41.77% 12.79% -29.47%
SHAREHOLDERS EQUITY
Retained Earnings -$86.94M -$84.94M -$69.38M
YoY Change 30.86% 22.42% 16.71%
Common Stock $74.85M $74.73M $72.78M
YoY Change 2.7% 2.68% 1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.09M -$10.21M $3.399M
YoY Change
Total Liabilities & Shareholders Equity $18.50M $22.99M $20.72M
YoY Change 0.62% 10.95% -43.66%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Registrant Name
EntityRegistrantName
PLx Pharma Inc.
dei Entity Small Business
EntitySmallBusiness
true
CY2019Q3 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
907130
CY2018Q4 plxp Accrued Bonuses And Severances Current
AccruedBonusesAndSeverancesCurrent
1048393
CY2019Q1 plxp Adjustments To Additional Paid In Capital Preferred Stock Beneficial Conversion Feature At Issuance
AdjustmentsToAdditionalPaidInCapitalPreferredStockBeneficialConversionFeatureAtIssuance
12692308
CY2019Q1 plxp Adjustments To Additional Paid In Capital Preferred Stock Beneficial Conversion Feature Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalPreferredStockBeneficialConversionFeatureDeemedDividend
-12692308
plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
13433397
plxp Beneficial Conversion Feature And Dividends Of Preferred Stock
BeneficialConversionFeatureAndDividendsOfPreferredStock
CY2019Q3 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
741089
CY2018Q4 plxp Dividends Payable Noncurrent
DividendsPayableNoncurrent
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-141263
plxp Increase Decrease In Bonuses And Severances
IncreaseDecreaseInBonusesAndSeverances
-94629
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
133410
plxp Increase Decrease In Interest Payable Net Excluding Related Parties
IncreaseDecreaseInInterestPayableNetExcludingRelatedParties
166442
plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-12538
plxp Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
CY2019Q3 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
462708
CY2018Q4 plxp Interest Payable Noncurrent
InterestPayableNoncurrent
309440
CY2019Q3 plxp Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
5
CY2019Q3 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
1392586
CY2018Q3 plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-3425073
plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-31935722
plxp Net Income Loss Available To Common Stockholders Before Impact Of Preferred Stock Participation Rights
NetIncomeLossAvailableToCommonStockholdersBeforeImpactOfPreferredStockParticipationRights
-2049885
plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
1941987
plxp Proceeds From Issuance Of Common Stock Net Issuance Costs
ProceedsFromIssuanceOfCommonStockNetIssuanceCosts
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1290839
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
687257
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74720150
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001497504
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9151854
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
plxp
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
72871317
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
128218
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
301735
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
311136
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
260577
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
247536
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
603314
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
765136
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
172438
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
185139
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10306370
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3911302
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10503537
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3911302
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q3 us-gaap Assets
Assets
22986740
CY2018Q4 us-gaap Assets
Assets
18388376
CY2019Q3 us-gaap Assets Current
AssetsCurrent
18759850
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14865410
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2847
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18509487
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14250267
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24404368
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16537259
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4259220
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7867109
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
18500000
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.50
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2646091
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9122990
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8743950
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9122990
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8743950
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
9123
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
8744
CY2018Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2019Q3 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
0
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2019Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
CY2018Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
174976
CY2019Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
73666
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
67714
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
126692
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145218
CY2019Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
10118838
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2537317
us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y109D
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2500000
CY2019Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5498391
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7017923
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
408803
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
7581521
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12398
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2503314
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1800159
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7180674
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5870745
CY2019Q3 us-gaap Goodwill
Goodwill
2061022
CY2018Q4 us-gaap Goodwill
Goodwill
2061022
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22107
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18234
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1703722
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3425073
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18502325
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2049885
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
820711
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
55405
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
524245
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-25912
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-50406
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-165618
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-458997
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
230053
CY2018Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
290773
us-gaap Interest Expense Debt
InterestExpenseDebt
805147
us-gaap Interest Expense Debt
InterestExpenseDebt
849457
us-gaap Interest Paid Net
InterestPaidNet
486902
us-gaap Interest Paid Net
InterestPaidNet
497136
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
40508
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
60366
CY2019Q3 us-gaap Inventory Net
InventoryNet
0
CY2018Q4 us-gaap Inventory Net
InventoryNet
0
CY2019Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
600000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1000000
us-gaap Inventory Write Down
InventoryWriteDown
us-gaap Inventory Write Down
InventoryWriteDown
770619
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
111621
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
77276
us-gaap Investment Income Interest
InvestmentIncomeInterest
329063
us-gaap Investment Income Interest
InvestmentIncomeInterest
219374
us-gaap Lease Cost
LeaseCost
113996
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
356196
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
101280
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
107911
CY2019Q3 us-gaap Liabilities
Liabilities
19533982
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
30132
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
60264
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
60819
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
262850
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
871541
CY2018Q4 us-gaap Liabilities
Liabilities
11944083
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22986740
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18388376
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6173884
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4732660
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3626168
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2909709
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1548864
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4280385
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13416065
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-134219
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-654870
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9022626
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7212239
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1703722
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3425073
us-gaap Net Income Loss
NetIncomeLoss
-18502325
us-gaap Net Income Loss
NetIncomeLoss
-2049885
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
4978592
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-3603404
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-10858751
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-9347296
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
837078
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
837078
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5379959
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-622300
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8057605
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6387840
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
3717343
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1392206
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1394230
us-gaap Operating Lease Expense
OperatingLeaseExpense
86890
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
763630
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
309239
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
454391
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
699996
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y255D
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3019303
us-gaap Operating Expenses
OperatingExpenses
10986291
us-gaap Operating Expenses
OperatingExpenses
8903171
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3676237
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2802773
us-gaap Operating Income Loss
OperatingIncomeLoss
-10444720
us-gaap Operating Income Loss
OperatingIncomeLoss
-8437725
us-gaap Operating Lease Cost
OperatingLeaseCost
273392
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
105072
CY2018Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
29753
us-gaap Operating Lease Expense
OperatingLeaseExpense
289553
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
309239
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
26935
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
488599
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
84281
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145661
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
654870
CY2019Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
311136
CY2018Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
13433397
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
311136
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
955000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
955000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
250363
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
421933
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain reclassifications have been made to the prior-year financial statements to conform to the current-year presentation.&nbsp; These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the reported results of operations.</div></div></div></div></div></div></div></div>
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13661578
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11442
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Revenues
Revenues
465446
CY2019Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
18234
us-gaap Repayments Of Debt
RepaymentsOfDebt
2187500
us-gaap Repayments Of Debt
RepaymentsOfDebt
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1214029
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1219144
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3805617
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3032426
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-84938093
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66435768
CY2019Q3 us-gaap Revenues
Revenues
41106
CY2018Q3 us-gaap Revenues
Revenues
216530
us-gaap Revenues
Revenues
541571
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
8.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
714350
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
150450
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1206709
us-gaap Share Based Compensation
ShareBasedCompensation
603314
us-gaap Share Based Compensation
ShareBasedCompensation
765136
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
991662
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
176380
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1744679
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.93
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.88
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.76
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49349
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y182D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y36D
us-gaap Stock Issued1
StockIssued1
45000
us-gaap Stock Issued1
StockIssued1
67500
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
13601
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
15340
CY2018Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2018Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2018Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2019Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2019Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
22500
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
462902
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1479085
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
281505
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
236095
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
247536
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
66232
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
276505
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
260577
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-10208820
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-4453944
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-13341068
us-gaap Sublease Income
SubleaseIncome
175557
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6444293
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
4616392
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
9898989
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
6554180
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
3399143
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
555508
CY2019Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
15000000
CY2018Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
15000000
CY2019Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
45000
CY2018Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
45000
CY2019Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
15000
CY2018Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2019Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
15000
CY2018Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2019Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
CY2019Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
13661578
CY2018Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><div style="display: inline; font-weight: bold;"></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><div style="display: inline; font-weight: bold;"></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, determining the fair value of tangible and intangible assets and liabilities acquired in business combinations, the fair value of warrant liabilities and other financial instruments, stock-based compensation, allowance for inventory obsolescence, allowance for doubtful accounts, contingent liabilities, the fair value and depreciable lives of long-lived tangible and intangible assets, and deferred taxes and the associated valuation allowance. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
us-gaap Variable Lease Cost
VariableLeaseCost
16161
CY2017Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14910
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8936255
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8735790
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8860168
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8730303
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8921345
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8735790
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8860168
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8730303

Files In Submission

Name View Source Status
0001437749-19-022041-index-headers.html Edgar Link pending
0001437749-19-022041-index.html Edgar Link pending
0001437749-19-022041.txt Edgar Link pending
0001437749-19-022041-xbrl.zip Edgar Link pending
ex_162264.htm Edgar Link pending
ex_162265.htm Edgar Link pending
ex_162266.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
plxp-20190930.xml Edgar Link completed
plxp-20190930.xsd Edgar Link pending
plxp-20190930_cal.xml Edgar Link unprocessable
plxp-20190930_def.xml Edgar Link unprocessable
plxp-20190930_lab.xml Edgar Link unprocessable
plxp-20190930_pre.xml Edgar Link unprocessable
plxp20190930_10q.htm Edgar Link pending
plxp20190930_10qimg001.jpg Edgar Link pending
plxp20190930_10qimg002.gif Edgar Link pending
plxp20190930_10qimg003.gif Edgar Link pending
plxp20190930_10qimg004.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending